Business Model

Novelgenix is a young  and  dynamic speciality pharmaceutical company whose core business is innovation and development of new niche products and registration of innovative patents that are licensed all over the world.
Novelgenix operates in all areas of life sciences and is constantly committed to improve people’s life quality in areas of health and well-being. Novelgenix  carries out an active role in discovering and treating diseases of high social impact.

  • Selecting the molecules : Through careful research Novelgenix identifies the opportunities that are both scientifically sound and highly profitable

  • Pharmaceutical Technology  CMAX  Technologies Canada : The team defines the formulation and ensures the development and the production are carried out efficiently by highly qualified manufacturer.
  • Clinical Studies : Syncron  Research Services Pvt. Ltd. : Novelgenix facilitates the plan for pre-clinical & clinical studies and co-ordinates their management. Novelgenix has a strong relationship with CRO’s world- wide and hospitals for clinical research.
  • Production : Novelgenix does not own any manufacturing plant or laboratory because it opt to use excellent partners net-work to match with our novel vision. Novelgenix has contract manufacturing partners of high standards with USFDA, MHRA and other Regulatory approved facilities from India & Thailand

  • Regulatory/ Licensing : - Once the registration strategy is decided, Novelgenix provides necessary support to their client through licensing partners and marketing partners world- wide.

  • Quality  of  the product, careful selection of client companies, reliable assistance in regulatory affairs and active marketing support  in the commercial phase of the product are the keys to success which Novelgenix’s choices become opportunities for its licenses.

Follow us on : 

    Home | Management| Board of Directors | Mission| Contact us | Query
Copyright 2012 novelgenix of right reserved.